Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$67.36 - $77.59 $747,696 - $861,249
-11,100 Reduced 79.86%
2,800 $205,000
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $860,410 - $1.01 Million
13,900 New
13,900 $929,000
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $1.07 Million - $1.2 Million
-17,900 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $1.08 Million - $1.35 Million
17,900 New
17,900 $1.17 Million
Q2 2021

Aug 16, 2021

SELL
$62.12 - $74.2 $577,716 - $690,060
-9,300 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$57.98 - $73.08 $133,354 - $168,084
2,300 Added 32.86%
9,300 $571,000
Q3 2020

Nov 16, 2020

SELL
$51.39 - $72.41 $303,201 - $427,219
-5,900 Reduced 45.74%
7,000 $487,000
Q2 2020

Aug 14, 2020

BUY
$39.55 - $54.65 $510,194 - $704,985
12,900 New
12,900 $684,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.34B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.